Can K-C capture
Kenvue benefits?

Slow growth legacy hygiene
biz sparks investor doubts 

Kimberly-Clark, the personal care giant, agreed to acquire Kenvue, the consumer health house of brands (inc. Tylenol, Listerine, Neutrogena) for $49Bn, in Nov'25. This monster deal due for completion in Q4'26, will take revenues to $32Bn+. The cost synergies are obvious, but in a new era of intensifying brand focus eg Reckitt, Unilever can it compete as a broad platform like P&G? Full investor analysis here, first